These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26144855)

  • 1. Dermatological adverse reactions to cancer chemotherapy.
    Pavey RA; Kambil SM; Bhat RM
    Indian J Dermatol Venereol Leprol; 2015; 81(4):434. PubMed ID: 26144855
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib.
    Steele JC; Triantafyllou A; Rajlawat BP; Field EA
    Clin Exp Dermatol; 2012 Jun; 37(4):432-3. PubMed ID: 22420895
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients.
    Vinay K; Yanamandra U; Dogra S; Handa S; Suri V; Kumari S; Khadwal A; Prakash G; Lad D; Varma S; Malhotra P
    Int J Dermatol; 2018 Mar; 57(3):332-338. PubMed ID: 29266186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors.
    Galimont-Collen AF; Vos LE; Lavrijsen AP; Ouwerkerk J; Gelderblom H
    Eur J Cancer; 2007 Mar; 43(5):845-51. PubMed ID: 17289377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
    Ocvirk J; Cencelj S
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
    Sibaud V; Fricain JC; Baran R; Robert C
    Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comedonal acneiform eruption following dovitinib therapy.
    Gracia-Cazaña T; Pastushenko I; Concellón MA; Grasa-Jordán MP
    Clin Exp Dermatol; 2014 Oct; 39(7):842-3. PubMed ID: 25196373
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized skin hyperpigmentation and longitudinal melanonychia secondary to treatment with hydroxychloroquine in systemic lupus erythematosus.
    Sifuentes Giraldo WA; Grandal Platero M; de la Puente Bujidos C; Gámir Gámir ML
    Reumatol Clin; 2013; 9(6):381-2. PubMed ID: 23481508
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
    Masson Regnault M; Gadaud N; Boulinguez S; Tournier E; Lamant L; Gladieff L; Roche H; Guenounou S; Recher C; Sibaud V
    Dermatology; 2015; 231(4):312-8. PubMed ID: 26422424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 11. Acneiform Rash With Ramucirumab and Paclitaxel in a Patient With Recurrent Esophageal Cancer.
    Moore DC
    Am J Ther; 2018; 25(5):e557-e558. PubMed ID: 28767454
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma.
    Kovalyshyn I; Bijal AD; Lacouture ME; Brownell I
    J Am Acad Dermatol; 2011 Sep; 65(3):657-659. PubMed ID: 21839325
    [No Abstract]   [Full Text] [Related]  

  • 13. Images in clinical medicine. Cetuximab-associated acneiform eruption.
    Moss JE; Burtness B
    N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
    [No Abstract]   [Full Text] [Related]  

  • 14. Acneiform eruption following molecular targeted chemotherapy.
    Vaccaro M; Barbuzza O; Pollicino A; Guarneri C
    Intern Med J; 2011 Apr; 41(4):361-2. PubMed ID: 21507168
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-related nail disease.
    Piraccini BM; Alessandrini A
    Clin Dermatol; 2013; 31(5):618-26. PubMed ID: 24079591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and pathophysiology of EGFRI dermatologic toxicities.
    Mitchell EP; Perez-Soler R; Van Cutsem E; Lacouture ME
    Oncology (Williston Park); 2007 Oct; 21(11 Suppl 5):4-9. PubMed ID: 18154212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced onycholysis.
    Makris A; Mortimer P; Powles TJ
    Eur J Cancer; 1996 Feb; 32A(2):374-5. PubMed ID: 8664062
    [No Abstract]   [Full Text] [Related]  

  • 18. Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma.
    Necessary CA; Roffwarg D; Ellis D
    J Am Acad Dermatol; 2014 Jul; 71(1):e23-4. PubMed ID: 24947708
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosaceiform eruption induced by cetuximab.
    Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
    Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced skin, nail and hair disorders.
    Valeyrie-Allanore L; Sassolas B; Roujeau JC
    Drug Saf; 2007; 30(11):1011-30. PubMed ID: 17973540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.